EZH2 and breast cancer: Although the effect of EZH2 or NSD2 on survival in BC patients has been previously described, this study is the first to offer a comprehensive analysis about the prognostic values of EZH2 and NSD2 for RFS, OS, DMFS, and PPS in a large group of BC patients.